Thomas J. Appio
2020
In 2020, Thomas J. Appio earned a total compensation of $3.8M as President Co, Head Bausch + Lomb/International at Valeant Pharmaceuticals International, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $558,000 |
|---|---|
| Option Awards | $540,362 |
| Salary | $775,000 |
| Stock Awards | $1,131,025 |
| Other | $824,000 |
| Total | $3,828,387 |
Appio received $1.1M in stock awards, accounting for 30% of the total pay in 2020.
Appio also received $558K in non-equity incentive plan, $540.4K in option awards, $775K in salary and $824K in other compensation.
Rankings
In 2020, Thomas J. Appio's compensation ranked 2,993rd out of 13,090 executives tracked by ExecPay. In other words, Appio earned more than 77.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,993 out of 13,090 | 77th |
Division Manufacturing | 1,164 out of 5,617 | 79th |
Major group Chemicals And Allied Products | 440 out of 2,248 | 80th |
Industry group Drugs | 382 out of 1,948 | 80th |
Industry Pharmaceutical Preparations | 283 out of 1,453 | 81st |
Source: SEC filing on May 2, 2022.
Appio's colleagues
We found four more compensation records of executives who worked with Thomas J. Appio at Valeant Pharmaceuticals International in 2020.
2020
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2020
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
2020
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2020
Sam Eldessouky
Valeant Pharmaceuticals International